Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults
2020 · The Lancet Global Health · 325 citations
https://doi.org/10.1016/s2214-109x(20)30069-3
M
Mingqiang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
483
Papers
21.5K
Citations
77
h-index
283
i10-index
Mingqiang Li is an academic researcher from Southwest University of Science and Technology. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & RNA Interference and Gene Delivery. The author has an h-index of 77, co-authored 411 publications.
ORCID: 0000-0002-5178-4138Papers by this author
worksAdherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population
2017 · Journal of the American College of Cardiology · 286 citations
https://doi.org/10.1016/j.jacc.2016.11.076
Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers
2020 · Science Advances · 178 citations
https://doi.org/10.1126/sciadv.aay7148
Spatiotemporal control of CRISPR/Cas9 gene editing
2021 · Signal Transduction and Targeted Therapy · 165 citations
https://doi.org/10.1038/s41392-021-00645-w
Possible absence of critical thickness and size effect in ultrathin perovskite ferroelectric films
2017 · Nature Communications · 164 citations
https://doi.org/10.1038/ncomms15549
Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure
2020 · Nano-Micro Letters · 112 citations
https://doi.org/10.1007/s40820-020-00550-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat